Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
3.720
-0.160 (-4.12%)
At close: Jul 19, 2024, 4:00 PM
3.780
+0.060 (1.61%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $2.97 million as of July 22, 2024. Its market cap has decreased by -93.75% in one year.
Market Cap
2.97M
Enterprise Value
2.69M
1-Year Change
-93.75%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $411.31M to $2.97M, a decrease of -99.28%. That is a compound annual growth rate of -79.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.60M | -58.73% |
| Dec 29, 2023 | 6.30M | -88.44% |
| Dec 30, 2022 | 54.50M | -67.71% |
| Dec 31, 2021 | 168.80M | -58.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healthcare Triangle | 3.20M |
| Aditxt | 3.19M |
| Protagenic Therapeutics | 3.12M |
| CNS Pharmaceuticals | 3.01M |
| Petros Pharmaceuticals | 3.01M |
| INVO Bioscience | 2.85M |
| TC Biopharm (Holdings) | 2.82M |
| Virax Biolabs Group | 2.76M |